Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + Dexamethasone Maintenance in Multiple Myeloma
NCT01296503Phase 3Completed
- Sponsor
- Grupo de Estudos Multicêntricos em Onco-Hematologia
- Start
- Oct 2003
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Grupo de Estudos Multicêntricos em Onco-Hematologia. Started Oct 2003; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01296503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296503.